Summary

Global Sanger Sequencing Service Market is expected to grow at a significant rate of around 10% during the forecast period. Sanger sequencing is a DNA sequencing method that was developed in the late 1970s and is still widely used today for a variety of applications, including genetic research, drug development, and clinical diagnostics. Sanger sequencing involves the use of fluorescently labeled nucleotides and chain-terminating dideoxynucleotides to create a series of DNA fragments that can be separated by size using capillary electrophoresis. The sanger sequencing service market is primarily driven by the growing demand for genetic research and personalized medicine. Genetic research has become increasingly important in fields such as oncology, neurology, and infectious diseases, and sanger sequencing is often used in the initial stages of research projects to generate high-quality DNA sequences that can be analyzed for variations and mutations. In addition to genetic research, sanger sequencing is also used in clinical diagnostics to identify genetic mutations that can lead to diseases such as cancer, cystic fibrosis, and Huntington's disease.

Microsynth AG; Thermo Fisher Scientific, Inc.; Azenta Life Sciences; GenHunter Corporation; LGC Biosearch Technologies; Laragen, Inc; STARSEQ GmbH; Medisupport SA; Quintara; and ciGenom Labs Pvt. Ltd. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
 
Insights Presented in the Report
“Amongst application, personalized medicine category to witness higher CAGR during the forecast period ”
Based on the application, the market is segmented into diagnostics, biomarkers and cancer, reproductive health, personalized medicine, forensics, and others. The personalized medicine is anticipated to grow with significant CAGR during the forecast period. Personalized medicine is a rapidly growing field that involves tailoring medical treatments to an individual's unique genetic makeup. Sanger sequencing, which is a method for DNA sequencing, plays a critical role in personalized medicine by enabling the identification of specific genetic mutations and variants that can inform personalized treatment plans. Sanger sequencing is increasingly being used in clinical trials to identify patients who may benefit from personalized treatments. Thus, the above mentioned factors are driving the market growth during the forecast period.

“Amongst end user, the hospitals & clinics category to hold a significant share in the market in 2021 ”
On the basis of end user, the market is segmented into academics and governmental organizations, pharmaceutical companies, hospitals & clinics, and others. The hospitals & clinics category held a significant share of the market in 2021. By using Sanger sequencing to identify specific genetic mutations and variants, hospitals and clinics can provide more personalized treatment plans for their patients. This has the potential to improve patient outcomes and reduce healthcare costs by reducing the need for trial-and-error treatments.

“Asia Pacific to witness higher CAGR during the forecast period”
Asia Pacific is expected to grow with significant CAGR during the forecast period. The growth of the APAC sanger sequencing service market is driven by various factors, including the increasing demand for genetic testing and personalized medicine, the growing prevalence of genetic disorders, and the rising focus on agriculture biotechnology. China is expected to dominate the market, owing to its large population and increasing demand for genetic testing. Japan is also a significant market, due to the presence of well-established research facilities and academic institutions.

Reasons to buy this report:
• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
• The report presents a quick review of overall industry performance at one glance.
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
• The study comprehensively covers the market across different segments.
• Deep dive regional level analysis of the industry.

Customization Options:
The global sanger sequencing service market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

ページTOPに戻る

Table of Contents

1 MARKET INTRODUCTION
1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation
2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1. Research Process of the Sanger Sequencing Service Market
2.2. Research Methodology of the Sanger Sequencing Service Market
2.3. Respondent Profile
3 MARKET SYNOPSIS
4 EXECUTIVE SUMMARY
5 IMPACT OF COVID-19 ON THE SANGER SEQUENCING SERVICE MARKET
6 SANGER SEQUENCING SERVICE MARKET REVENUE (USD BN), 2020-2028F
7 MARKET INSIGHTS BY APPLICATION
7.1. Diagnostics
7.2. Biomarkers and Cancer
7.3. Reproductive Health
7.4. Personalized Medicine
7.5. Forensics
7.6. Others
8 MARKET INSIGHTS BY END USER
8.1. Academic & Government Research Institutes
8.2. Pharmaceutical Companies
8.3. Hospitals & Clinics
8.4. Others
9 MARKET INSIGHTS BY REGION
9.1. North America
9.1.1. U.S.
9.1.2. Canada
9.1.3. Rest of North America
9.2. Europe
9.2.1. Germany
9.2.2. U.K.
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. Rest of Asia-Pacific
9.4. Rest of World
10 SANGER SEQUENCING SERVICE MARKET DYNAMICS
10.1. Market Drivers
10.2. Market Challenges
11 SANGER SEQUENCING SERVICE MARKET OPPORTUNITIES
12 SANGER SEQUENCING SERVICE MARKET TRENDS
13 DEMAND AND SUPPLY-SIDE ANALYSIS
13.1. Demand Side Analysis
13.2. Supply Side Analysis
14 VALUE CHAIN ANALYSIS
15 COMPETITIVE SCENARIO
15.1. Competitive Landscape
15.1.1. Porters Fiver Forces Analysis
16 COMPANY PROFILED
16.1. Microsynth AG
16.2. Thermo Fisher Scientific, Inc.
16.3. Azenta Life Sciences
16.4. GenHunter Corporation
16.5. LGC Biosearch Technologies
16.6. Laragen, Inc
16.7. STARSEQ GmbH
16.8. Medisupport SA
16.9. Quintara
16.10. SciGenom Labs Pvt. Ltd.
17 DISCLAIMER